© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
About N/A of shares are held by financial institutions. US BANCORP \DE\ is the top corporate investor, holding 0 shares valued at -. A 0% stake in POINT Biopharma Global Inc. is owned by the company. UBS ASSET MANAGEMENT AMERICAS INC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the PNT insiders holding of N/A of the stake in company, SILBER ALLAN C, Executive Chairman, holds the largest shares of 4.27M. MCCANN JOE A., Chief Executive Officer, is the second largest PNT insider with ownership of 3.62M shares. FLESHNER NEIL E., Chief Medical Officer, stands third with possession of 3.02M shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PNT shares is N/A, representing N/A of the company's common stock.
US BANCORP \DE\, in the last quarter, reduced its stake in PNT by -100% restricting it's holding to 0 shares of worth nearly -. UBS ASSET MANAGEMENT AMERICAS INC also lessened -100% of the PNT shares from its portfolio, reducing its holding to 0 shares of worth -. AMERICAN INTERNATIONAL GROUP, INC. also shunned PNT shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, LMR PARTNERS LLP increased its stake in PNT by 100% in the last quarter. The institutional holder raised its holding to 518.7 thousand shares having worth more than $6.48M. JET CAPITAL INVESTORS L P also added 100% more shares of PNT to its portfolio, raising its holding to 2.8 thousand shares of worth $35.00K. RONALD BLUE TRUST, INC. also increased its PNT shares holding by 100% which brought its holding to 127 shares worth $1.00K.
The insider with the most stakes in PNT is SILBER ALLAN C , Executive Chairman at the company. Additionally, PNT stock is highly held by Chief Executive Officer MCCANN JOE A. and Chief Medical Officer FLESHNER NEIL E. among others.
Company executives, directors, and other insiders own N/A percent of POINT Biopharma Global Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which PNT insiders have sold stock, totaling 0 shares. Insiders that have sold shares include BVF PARTNERS L P/IL and FLESHNER NEIL E..
There have been 0 transaction(s) during the past 6-months in which POINT Biopharma Global Inc. insiders have bought stock, totalling 0 shares
Around 0 POINT Biopharma Global Inc. shares are held by insiders, which represents about N/A of PNT stock.
PNT Executive Chairman, SILBER ALLAN C holds the largest portfolio of the company's shares. PNT shares owned by SILBER total nearly 4.27 million.
US BANCORP \DE\ is the largest institutional owner in PNT which holds 0 shares worth - or 0% of the total PNT shares outstanding followed by UBS ASSET MANAGEMENT AMERICAS INC with ownership of 0 shares representing 0% of the PNT ownership. LMR PARTNERS LLP is the third largest stakeholder with 518.7 thousand shares or 0.49% of the ownership worth more than $6.48M.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PNT is concerned, it is a stock which is optionable.
Number of PNT shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, N/A shares of PNT are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PNT has N/A shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PNT is N/A.